PNU 166945
Alternative Names: FCE 28161Latest Information Update: 06 Aug 2002
At a glance
- Originator Pharmacia Corporation
- Class Antineoplastics; Paclitaxels; Taxanes
- Mechanism of Action Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours